Compare Aurora Cannabis Inc (ACB) vs Global X Cloud Computing ETF (CLOU) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

CLOU trades at $23.43, up 0.9% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF provides exposure to the cloud computing sector, though key valuation and profitability metrics are not disclosed in the provided data. Recent news highlights mixed performance for cloud ETFs, with some articles discussing growth potential from AI platforms while others note significant past losses in similar funds.

The outlook for CLOU hinges on broader technology and cloud computing trends, with AI adoption presenting a potential catalyst. Risks include sector volatility, competitive pressures, and regulatory developments, as seen in Europe's push for tech sovereignty. Investors should weigh the ETF's diversification benefits against the inherent uncertainties in the tech landscape.